10-Year Benefit With FFR-Guided Complete Revascularization for STEMI



(MedPage Today) — For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, 10-year data from the DANAMI-3-PRIMULTI trial brought greater assurance that complete revascularization has clinical benefits.
At…



Source link : https://www.medpagetoday.com/meetingcoverage/europcr/115681

Author :

Publish date : 2025-05-20 20:26:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version